These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1361447)

  • 1. The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole.
    D'Aquila PS; Sias A; Gessa GL; Serra G
    Eur J Pharmacol; 1992 Dec; 224(2-3):199-202. PubMed ID: 1361447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term imipramine effects are prevented by NMDA receptor blockade.
    De Montis MG; Gambarana C; Meloni D; Taddei I; Tagliamonte A
    Brain Res; 1993 Mar; 606(1):63-7. PubMed ID: 8096430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats.
    Meloni D; Gambarana C; De Montis MG; Dal Prá P; Taddei I; Tagliamonte A
    Pharmacol Biochem Behav; 1993 Oct; 46(2):423-6. PubMed ID: 7903459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dizocilpine prevents the enhanced locomotor response to quinpirole induced by repeated electroconvulsive shock.
    D'Aquila PS; Collu M; Gessa GL; Serra G
    Eur J Pharmacol; 1997 Jul; 330(1):11-4. PubMed ID: 9228409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alpha 1 receptors in the behavioural supersensitivity to D2 agonists induced by chronic treatment with imipramine.
    D'Aquila PS; Collu M; Gessa GL; Serra G
    Pharmacol Res; 1992 Jan; 25(1):95-101. PubMed ID: 1346718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor inhibition prevents tolerance to cocaine.
    De Montis MG; Devoto P; Meloni D; Gambarana C; Giorgi G; Tagliamonte A
    Pharmacol Biochem Behav; 1992 May; 42(1):179-82. PubMed ID: 1356273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
    Ferré S; Giménez-Llort L; Artigas F; Martínez E
    Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
    Dall'olio R; Rimondini R; Gandolfi O
    Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
    Cook CD; Newman JL; Winfree JC; Beardsley PM
    Pharmacol Biochem Behav; 2004 Feb; 77(2):309-18. PubMed ID: 14751459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of dopamine-mediated behaviour by the NMDA antagonists MK-801 and CPP: similarities with repeated electroconvulsive shock.
    Smith SE; Acton L; Sharp T
    Psychopharmacology (Berl); 1997 Sep; 133(1):85-94. PubMed ID: 9335085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
    Maj J; Papp M; Skuza G; Bigajska K; Zazula M
    J Neural Transm; 1989; 76(1):29-38. PubMed ID: 2565359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated.
    Ogren SO; Goldstein M
    Neuropsychopharmacology; 1994 Nov; 11(3):167-77. PubMed ID: 7865098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine prevents imipramine-induced behavioural sensitization to the dopamine D(2)-like receptor agonist quinpirole.
    D'Aquila PS; Peana AT; Tanda O; Serra G
    Eur J Pharmacol; 2001 Mar; 416(1-2):107-11. PubMed ID: 11282119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD.
    Bibbiani F; Oh JD; Kielaite A; Collins MA; Smith C; Chase TN
    Exp Neurol; 2005 Dec; 196(2):422-9. PubMed ID: 16203001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
    Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lithium chloride fails to prevent imipramine-induced sensitization to the dopamine D(2)-like receptor agonist quinpirole.
    D'Aquila PS; Collu M; Devoto P; Serra G
    Eur J Pharmacol; 2000 Apr; 395(2):157-60. PubMed ID: 10794822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of chronic treatment with antidepressant drugs and intermittent treatment with a dopamine agonist.
    Papp M; Muscat R; Willner P
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):121-5. PubMed ID: 1353000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.